New Nasal Spray to Enhance Women's Libido

Buy Lab Tests Online

madman

Super Moderator
Nasal Spray Increases Libido in Women

A new nasal spray is being tested on hundreds of Australian women who struggle with low sex drive.

There is currently no approved treatment for women of child-bearing age to help boost their lagging libido, which can cause them considerable distress.

"When women go to their doctor and they say they've lost interest in sex and it's affecting them and their relationship and their wellbeing, they're often too quickly dismissed," said Monash University's Professor Susan Davis, Director of the Women's Health Research Program.

"They are told it's because they're working and they've got kids and they've got stress and not sleeping," she said.


Professor Davis is investigating a molecule called BP101 to see whether it can help treat women.

"This molecule acts within the central brain pathways, particularly what we call the GABA pathway that influences sexual behavior," she said.

The spray delivers the synthetic peptide to the nerves in the nasal cavity and into the brain.


About 480 women aged between 21 and 50 are being recruited at 10 sites across Australia.

A previous pilot study involving up to 200 women was used to test the therapy's safety and effectiveness.

"This molecule has been investigated in terms of its safety," Professor Davis said.

The latest development comes more than 20 years after the arrival of Viagra in Australia to treat male sexual dysfunction.

"We have treatments for male sexual dysfunction, we have none for female sexual dysfunction in premenopausal women," said Professor Davis.

New research by Monash researchers also uncovered the extent of the problem among Australian women.

A large study that was published last year found that about 10 percent of women aged 18 to 39 experienced low sexual desire, causing them considerable distress.

The prevalence of sexual dysfunction escalates with age with about one in three women aged 40 to 65 experiencing low sexual desire.

"The impact on their psychological wellbeing is as severe as having a chronic condition like type 2 diabetes or severe lower back pain," Professor Davis said.


Only last year, testosterone was approved as a treatment for postmenopausal women.

Screenshot (3912).png
 
Last edited by a moderator:
Defy Medical TRT clinic doctor
BP101 Peptide Promotes Female Sexual Receptivity in the Rat (2017)


In summary, BP101 displays a potent stimulatory effect on sexual motivation in female rats. The MPA seems to be the probable site of its action. The effect of BP101, when infused directly into the brain was relatively more pronounced in female rats primed with lower estrogen doses, although its action was still pronounced in “high” estrogen primed rats, making the data relevant to pre-and postmenopausal women with various hormonal statuses.

BP101 has successfully passed phase 1 clinical studies, where it demonstrated high safety, and currently undergoing a randomized, double-blinded, placebo-controlled phase 2 study to measure its efficacy.
 

Attachments

  • 2021MAR19-BP101-1-s2.0-S1743609517300553-main.pdf
    1.1 MB · Views: 143
PT-141 can be dissolved and "snorted", but it's nowhere near as effective as when injected. Just go get some quality PT-141 and give it a try. The good stuff (not *research* peptides) is the bomb!
 
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

bodybuilder test discounted labs
cheap enclomiphene
TRT in UK Balance my hormones
Discounted Labs
Testosterone Doctor Near Me
Testosterone books nelson vergel
nelson vergel coaching for men
Register on ExcelMale.com
Trimix HCG Offer Excelmale
BUY HCG CIALIS

Online statistics

Members online
4
Guests online
7
Total visitors
11

Latest posts

Top